Hanall Biopharma Market Cap

Hanall Biopharma has a market cap or net worth of 2.62 trillion as of April 28, 2026. Its market cap has increased by 92.94% in one year.

Market Cap

2.62T

Enterprise Value

2.62T

Revenue

155.18B

Ranking

n/a

PE Ratio

n/a

Stock Price

49,500.00

Market Cap Chart

Since August 30, 1995, Hanall Biopharma's market cap has increased from 26.30B to 2.62T, an increase of 9,844.04%. That is a compound annual growth rate of 16.17%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	2,615.21B	17.72%
Dec 30, 2025	2,221.62B	13.35%
Dec 30, 2024	1,959.95B	-12.72%
Dec 28, 2023	2,245.71B	148.89%
Dec 29, 2022	902.29B	-16.29%
Dec 30, 2021	1,077.89B	-43.84%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Celltrion Pharm	2,560.02B
Daewoong Pharmaceutical	1,721.34B
GC Biopharma	1,616.10B
Chong Kun Dang Pharmaceutical	1,159.49B
DongKook Pharmaceutical	1,141.30B
Hanmi Pharm.	6,270.37B
Yuhan	6,958.57B
Daewoong	948.66B

Market Cap Rankings